cmcmaster/rheumatology_pbs_schedule · Datasets at Hugging Face

pbs_code stringlengths 5 6	drug stringclasses 15 values	brand stringclasses 29 values	formulation stringclasses 35 values	indication stringclasses 7 values	treatment_phase stringclasses 53 values	streamlined_code stringclasses 33 values	online_application bool 2 classes	authority_method stringclasses 2 values	hospital_type stringclasses 3 values	schedule_code int64 4.03k 4.03k	schedule_year int64 2.02k 2.02k	schedule_month stringclasses 1 value
12348X	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12348X	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12348X	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12348X	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12348X	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
13689L	baricitinib	Olumiant	Tablet 2 mg	rheumatoid arthritis	Subsequent continuing treatment	14499	true	STREAMLINED	Any	4,030	2,024	AUGUST
13731Q	tocilizumab	Actemra	Concentrate for injection 400 mg in 20 mL	rheumatoid arthritis	Subsequent continuing treatment	14485	true	STREAMLINED	Private	4,030	2,024	AUGUST
11742B	tocilizumab	Actemra ACTPen	Injection 162 mg in 0.9 mL single use pre-filled pen	juvenile idiopathic arthritis	Continuing treatment	14150	true	STREAMLINED	Any	4,030	2,024	AUGUST
12621G	upadacitinib	Rinvoq	Tablet 15 mg	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12621G	upadacitinib	Rinvoq	Tablet 15 mg	ankylosing spondylitis	Continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12400P	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12209N	ixekizumab	Taltz	Injection 80 mg in 1 mL single dose pre-filled pen	ankylosing spondylitis	Continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12209N	ixekizumab	Taltz	Injection 80 mg in 1 mL single dose pre-filled pen	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12365T	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	11604	true	STREAMLINED	Any	4,030	2,024	AUGUST
12365T	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	11604	true	STREAMLINED	Any	4,030	2,024	AUGUST
12365T	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	11604	true	STREAMLINED	Any	4,030	2,024	AUGUST
12365T	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	11604	true	STREAMLINED	Any	4,030	2,024	AUGUST
12365T	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	11604	true	STREAMLINED	Any	4,030	2,024	AUGUST
13057F	infliximab	Remsima SC	Solution for injection 120 mg in 1 mL pre-filled syringe	ankylosing spondylitis	Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12399N	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12378L	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	psoriatic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12013G	certolizumab pegol	Cimzia	Solution for injection 200 mg in 1 mL pre-filled pen	non-radiographic axial spondyloarthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12013G	certolizumab pegol	Cimzia	Solution for injection 200 mg in 1 mL pre-filled pen	non-radiographic axial spondyloarthritis	Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12443X	adalimumab	Humira	Injection 20 mg in 0.2 mL pre-filled syringe	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
12443X	adalimumab	Humira	Injection 20 mg in 0.2 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
12443X	adalimumab	Humira	Injection 20 mg in 0.2 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
12443X	adalimumab	Humira	Injection 20 mg in 0.2 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
13349N	tofacitinib	Xeljanz	Tablet 5 mg	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13349N	tofacitinib	Xeljanz	Tablet 5 mg	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13349N	tofacitinib	Xeljanz	Tablet 5 mg	ankylosing spondylitis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13349N	tofacitinib	Xeljanz	Tablet 5 mg	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9036N	etanercept	Enbrel	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	psoriatic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9036N	etanercept	Enbrel	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
10893H	secukinumab	Cosentyx	Injection 150 mg in 1 mL pre-filled pen	ankylosing spondylitis	Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13707K	etanercept	Brenzys	Injections 50 mg in 1 mL single use pre-filled syringes, 4	rheumatoid arthritis	First continuing treatment	14629	true	STREAMLINED	Any	4,030	2,024	AUGUST
9035M	etanercept	Enbrel	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	psoriatic arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9035M	etanercept	Enbrel	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	psoriatic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9035M	etanercept	Enbrel	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	psoriatic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9035M	etanercept	Enbrel	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	psoriatic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13705H	abatacept	Orencia	Powder for I.V. infusion 250 mg	rheumatoid arthritis	Subsequent continuing treatment	14555	true	STREAMLINED	Private	4,030	2,024	AUGUST
13744J	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13744J	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9078T	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	ankylosing spondylitis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST

12348X

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12348X

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12348X

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12348X

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12348X

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

13689L

baricitinib

Olumiant

Tablet 2 mg

rheumatoid arthritis

Subsequent continuing treatment

14499

true

STREAMLINED

Any

4,030

2,024

AUGUST

13731Q

tocilizumab

Actemra

Concentrate for injection 400 mg in 20 mL

rheumatoid arthritis

Subsequent continuing treatment

14485

true

STREAMLINED

Private

4,030

2,024

AUGUST

11742B

tocilizumab

Actemra ACTPen

Injection 162 mg in 0.9 mL single use pre-filled pen

juvenile idiopathic arthritis

Continuing treatment

14150

true

STREAMLINED

Any

4,030

2,024

AUGUST

12621G

upadacitinib

Rinvoq

Tablet 15 mg

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12621G

upadacitinib

Rinvoq

Tablet 15 mg

ankylosing spondylitis

Continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12400P

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12209N

ixekizumab

Taltz

Injection 80 mg in 1 mL single dose pre-filled pen

ankylosing spondylitis

Continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12209N

ixekizumab

Taltz

Injection 80 mg in 1 mL single dose pre-filled pen

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12365T

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

11604

true

STREAMLINED

Any

4,030

2,024

AUGUST

12365T

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

11604

true

STREAMLINED

Any

4,030

2,024

AUGUST

12365T

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

11604

true

STREAMLINED

Any

4,030

2,024

AUGUST

12365T

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

11604

true

STREAMLINED

Any

4,030

2,024

AUGUST

12365T

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

11604

true

STREAMLINED

Any

4,030

2,024

AUGUST

13057F

infliximab

Remsima SC

Solution for injection 120 mg in 1 mL pre-filled syringe

ankylosing spondylitis

Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12399N

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12378L

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

psoriatic arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12013G

certolizumab pegol

Cimzia

Solution for injection 200 mg in 1 mL pre-filled pen

non-radiographic axial spondyloarthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12013G

certolizumab pegol

Cimzia

Solution for injection 200 mg in 1 mL pre-filled pen

non-radiographic axial spondyloarthritis

Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12443X

adalimumab

Humira

Injection 20 mg in 0.2 mL pre-filled syringe

juvenile idiopathic arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

12443X

adalimumab

Humira

Injection 20 mg in 0.2 mL pre-filled syringe

juvenile idiopathic arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

12443X

adalimumab

Humira

Injection 20 mg in 0.2 mL pre-filled syringe

juvenile idiopathic arthritis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

12443X

adalimumab

Humira

Injection 20 mg in 0.2 mL pre-filled syringe

juvenile idiopathic arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

13349N

tofacitinib

Xeljanz

Tablet 5 mg

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13349N

tofacitinib

Xeljanz

Tablet 5 mg

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13349N

tofacitinib

Xeljanz

Tablet 5 mg

ankylosing spondylitis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13349N

tofacitinib

Xeljanz

Tablet 5 mg

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9036N

etanercept

Enbrel

Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL

psoriatic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9036N

etanercept

Enbrel

Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

10893H

secukinumab

Cosentyx

Injection 150 mg in 1 mL pre-filled pen

ankylosing spondylitis

Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13707K

etanercept

Brenzys

Injections 50 mg in 1 mL single use pre-filled syringes, 4

rheumatoid arthritis

First continuing treatment

14629

true

STREAMLINED

Any

4,030

2,024

AUGUST

9035M

etanercept

Enbrel

Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL

psoriatic arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9035M

etanercept

Enbrel

Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL

psoriatic arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9035M

etanercept

Enbrel

Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL

psoriatic arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9035M

etanercept

Enbrel

Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL

psoriatic arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13705H

abatacept

Orencia

Powder for I.V. infusion 250 mg

rheumatoid arthritis

Subsequent continuing treatment

14555

true

STREAMLINED

Private

4,030

2,024

AUGUST

13744J

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13744J

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9078T

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

ankylosing spondylitis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST